Whitney Evans, Director of Nutrition and Scientific Affairs at Danone U.S., says that about 10 percent of adults in the United States have used or are currently taking a GLP-1 drug, and over half of American adults meet the criteria for the medication
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to reveal predispositions in peptide signaling pathways
Realistic expectations, stated plainly: If the named ingredients absorb transdermally at meaningful concentrations - the open question this category can't yet answer from published literature - buyers in the right profile may notice gradual improvements in appetite management, reduced urgency around cravings, and steadier energy through the day
Until larger human trials are available, most clinicians recommend empty-stomach administration for both oral and sublingual routes